At A Glance
1
Immunotech Laboratories, Inc.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees4
Fundamentals
How The Business Makes Money
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.
Industry Medical - Pharmaceuticals
Activity
What Changed Recently
No significant events in the past 90 days.